Company:  SYNLOGIC, INC. (SYBX)
Form Type:  8-K
Filing Date:  6/12/2019 
CIK:  0001527599 
Address:  301 BINNEY STREET
SUITE 402
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617-401-9975 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.88  
Change: 
0.27 (5.86%)  
Trade Time: 
03:19 PM EST  
Market Cap: 
$154.79M
Trade SYBX now with 

© 2019  
Description of Business
We are a clinical-stage biopharmaceutical company focused on advancing our proprietary drug discovery and development platform to create Synthetic Biotic(TM) medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer. Synthetic Biotic medicines are generated by applying the principles and tools of synthetic biology to engineer beneficial microbes to perform or deliver critical therapeutic functions. As living medicines, Synthetic Biotic medicines can be designed to sense a local disease context within a patient's body and to respond by metabolizing a toxic substance, compensating for missing or damaged metabolic pathways in patients, or by delivering combinations of therapeutic factors.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02 Unregistered Sale of Equity Securities
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 4.1
  EXHIBIT 10.1
  EXHIBIT 99.1
  EXHIBIT 99.2